Skip to main content

One Year In, TMC’s Helix Park Proves to be a Powerful Innovation Hub

Published Nov 07, 2024 by Hailea Schultz

Helix Park

Nearly one year since launching its first phase, the Texas Medical Center’s Helix Park is already proving to be a powerful catalyst for innovation, attracting a range of life sciences companies and bolstering collaboration between industry and academia.  

The 37-acre campus opened with the TMC3 Collaborative Building and Dynamic One Building, now home to prestigious institutions like Baylor College of Medicine, MD Anderson Cancer Center, Houston Methodist, Texas A&M University and UTHealth. Chicago-based venture capital firm Portal Innovations also joined the campus last year, occupying the entire third floor of the Collaborative Building with a 30,000-square-foot space. 

Growth continues at Helix Park as local institutions and companies expand their research initiatives and establish a stronger presence on campus. Rice University recently launched RBL LLC, a venture creation studio designed to act as a direct pipeline for new companies built around the technologies developed at its Biotech Launch Pad, established last year.  

“Leveraging Rice University’s Biotech Launch Pad breakthroughs and pairing it with the world-class translational infrastructure of TMC Helix Park well positions RBL to drive unprecedented advances in patient care,” said William McKeon, President and CEO of TMC, in a statement. “This partnership between academia, industry and health care is exactly what’s needed to transform medical discoveries into real-world solutions that improve lives globally.” 

In September, March Biosciences, an emerging clinical-stage biotech company spun off from Baylor College of Medicine, Houston Methodist Hospital, and Texas Children’s Hospital’s Center for Cell and Gene Therapy, moved to the Helix Park campus. Shortly after the move, March Biosciences successfully closed an oversubscribed $28.4 million Series A financing round. This funding will support the Phase 2 clinical development of MB-105, the company’s innovative cancer-fighting therapy.  

Switzerland-based biotech company Artidis also recently expanded to Helix Park, securing 2,000 square feet in Portal Innovations’ suite within the Collaborative Building, according to the Houston Business Journal. The company uses nanotechnology to rapidly diagnose cancer and develop personalized treatment plans. 

MD Anderson Cancer Center is also increasing its footprint at TMC with a new $239 million, 281,254-square-foot research facility featuring lab and office space. According to the Houston Business Journal, the facility, set for completion in 2028, will focus on advancing preclinical research. 

Additionally, the campus welcomed its first restaurant, Ojo de Agua, which offers a blend of Mexican and Mediterranean cuisine, contributing to Helix Park’s vision of becoming a premier destination. 

“We are excited to introduce Ojo de Agua to the Texas Medical Center community and present a new spot where members and visitors can connect, celebrate and collaborate while enjoying a unique culinary experience,” said McKeon in a statement. “Food has a way of bringing people together and as our campus continues to welcome visitors from all over the world, Ojo de Agua will showcase high quality, fresh ingredients that reflect the vibrancy and diversity of our community.” 

Learn more about the growth happening at TMC at the Partnership’s State of the Texas Medical Center event on November 14. 

Related News

Life Sciences

Bayou City Bio Pulse: Driving Houston's Life Sciences Growth

12/19/24
Houston's life sciences ecosystem is on the rise, and the Bayou City Bio Pulse is at the heart of this transformation. Launched in fall 2023 by the Greater Houston Partnership’s Life Science Committee, this bi-monthly event series is reshaping how the region's life sciences community connects, innovates and thrives. "Collide to Innovate" Under the motto "Collide to Innovate," Bayou City Bio Pulse aims to bring stakeholders together from across the Greater Houston area to explore the region's leading life sciences hubs. From the Texas Medical Center to Pearland, The Woodlands, and Sugar Land, these events spotlight over 8 million square feet of life sciences and biotechnology spaces, fostering collaboration and showcasing Houston's unparalleled assets. A Platform for Connection and Innovation Each Bayou City Bio Pulse event, organized in collaboration with BioHouston and other committee members, offers unique opportunities for networking, learning, and exploration. Attendees dive into critical topics such as funding, workforce development, artificial intelligence, and the future of innovative workspaces. Complemented by site tours, these gatherings provide an insider’s view into the cutting-edge advancements that are solidifying Houston’s status as a global leader in life sciences and biotechnology. Eric Johnson, Executive Managing Director of National Healthcare Advisory Services at Transwestern, highlights the initiative’s impact: “We’re really excited about what TMC is doing, what the Greater Houston Partnership’s doing and galvanizing our region to propel more life sciences growth here in Houston," said Eric Johnson, Executive Managing Director, National Healthcare Advisory Services, Transwestern. "The efforts of the Partnership’s life sciences committee has made visible strides to boost the cohesiveness and interaction among the many major players in our ecosystem, with opportunities for engagement like the Bayou City Bio Pulse. As we continue to build on successes, we see Houston emerging as a premier destination for life sciences and biotechnology.” Building Momentum Since its debut, Bayou City Bio Pulse has hosted seven events, drawing over 800 participants and doubling attendance from 2023 to 2024. This growing momentum underscores the region’s enthusiasm for collaboration and innovation within the life sciences sector. Shaping Houston’s Future in Life Sciences Looking ahead, the Bayou City Bio Pulse series is poised to amplify its reach and impact. By fostering connections and enhancing awareness of the region's strengths, it continues to support Houston’s evolution as a hub for life sciences and biotechnology. For businesses and innovators in Houston’s life sciences community, Bayou City Bio Pulse is more than an event series—it’s a catalyst for growth and a platform for shaping the future. Learn more about Houston’s life sciences industry.  Download the Partnership's 2024 Impact Report.
Read More
Economic Development

San Jacinto College and CellReady Launch Program to Accelerate Cell Therapy Workforce Development

12/17/24
PASADENA, Texas – The San Jacinto College Center for Biotechnology has partnered with CellReady, a privately held cell therapy contract development and manufacturing organization, to launch an innovative, fast-track training curriculum for new hires in biomanufacturing. This four-week program is designed to significantly shorten onboarding time for manufacturing associates, providing them with concentrated and rigorous hands-on training to jumpstart their readiness to work in advanced cell therapy manufacturing.  Over the course of the program, trainees undergo 160 hours of both theoretical and practical, hands-on learning that cover the fundamentals of biomanufacturing through the operation of advanced workflows. The curriculum prepares new hires for the production of cell therapies, a cutting-edge cancer treatment, using the G-Rex cell production platform. The training, which took place at CellReady’s manufacturing site in Houston, was delivered by San Jacinto College Biotechnology faculty members, in collaboration with CellReady’s training team. “To our knowledge, this is the first collaboration of its kind between a community college and a cell therapy manufacturer to develop an intensive onboarding curriculum tailored specifically for cell therapy manufacturing technicians,” said Dr. Chris Wild, San Jacinto College assistant vice chancellor of biotechnology. “Together with CellReady, we’ve created a path to rapidly train professionals with advanced, hands-on techniques, using the G-Rex cell production platform, which is widely used in the industry today.”  This joint initiative provides clear benefits to all stakeholders. For San Jacinto College, it underscores the institution’s commitment to meeting industry needs with innovative, real-world training.  CellReady gains a streamlined, effective approach to onboarding that enables new technicians to make an immediate impact post-training. At the conclusion of the program, trainees are equipped with the skills and knowledge needed to manufacture cell therapies. Dr. Ignacio Nunez, CellReady’s chief operating officer, was impressed with the training provided and the speed that employees were able to grasp the critical components of the manufacturing process, stating “Thanks to the training program developed and delivered by San Jacinto College and CellReady, we were able to provide our new hires with the essential knowledge and skills to work in a GMP environment. In collaboration with San Jacinto College, we have debottlenecked operator qualification and made great strides toward our mission of bringing more of these life-saving therapies to patients one G-Rex at a time.” “This program not only equips new team members with qualifiable skills to contribute immediately upon completion of the training program, but it also sets a new standard for how training can be delivered in a highly regulated field,” said Dr. Nicole Bradley, program director for the Center for Biotechnology. The program’s success has inspired plans for additional training sessions to onboard future manufacturing professionals at CellReady, further strengthening the relationship between San Jacinto College and CellReady. The training curriculum for cell therapy developed in collaboration with this industry leader will be available as a program offering through the San Jacinto Center for Biotechnology. About CellReady CellReady is the world's first and only G-Rex centric contract development and manufacturing organization (CDMO) specializing in G-Rex based cell and gene-modified cell therapy development and manufacturing. The company offers a wide range of services to support the development and commercialization of these therapies. CellReady's mission is to create hope for cancer patients, one G-Rex® process at a time. About San Jacinto College Surrounded by monuments of history, evolving industries, maritime enterprises of today, and the space age of tomorrow, San Jacinto College has served the people of East Harris County, Texas, since 1961. The College is one of the top 10 community colleges in the nation as designated by the Aspen Institute and was named an Achieving the Dream Leader College of Distinction in 2020. The College is a Hispanic-Serving Institution that spans five campuses, serving approximately 45,000 credit and non-credit students annually. It offers more than 200 degrees and certificates across eight major areas of study that put students on a path to transfer to four-year institutions or enter the workforce. The College is fiscally sound, holding bond ratings of AA+ by Standard & Poor’s and Aa2 by Moody’s.
Read More

Related Events

Executive Partners